Advances with bisphosphonates in the treatment of metabolic bone diseases. Introduction
Osteoporos Int
.
2001 Dec:12 Suppl 3:S1-2.
doi: 10.1007/pl00014040.
Author
R Lindsay
1
Affiliation
1
Internal Medicine, Helen Hayes Hospital, Haverstraw, NY 10993, USA.
PMID:
11846335
DOI:
10.1007/pl00014040
No abstract available
MeSH terms
Bone Density / drug effects
Bone Diseases, Metabolic / drug therapy*
Bone Diseases, Metabolic / physiopathology
Diphosphonates / therapeutic use*
Humans
Substances
Diphosphonates